Pharmacovigilance Inspections
Explore all topics, guides, and frameworks related to Pharmacovigilance Inspections.
Articles in this section
10- What Is a QPPV Inspection? Explains what people mean by a QPPV inspection, how QPPV-focused inspection activity fits within the wider pharmacovigilance inspection framework, what inspectors may test, and how effective oversight is demonstrated without treating internal governance conventions as legal requirements. Read Article →
- What Is a Pharmacovigilance Inspection? Explains how competent authorities inspect pharmacovigilance systems to assess compliance and effectiveness, how inspection scope is selected, what evidence inspectors may examine and how continuous readiness differs from assembling a last-minute inspection pack. Read Article →
- Pharmacovigilance Inspections Explains the EU pharmacovigilance inspection framework, inspection types and lifecycle, the relationship between the PSMF and inspection scope, evidence and interview methods, QPPV responsibilities, findings, CAPA and regulatory follow-up. Read Article →
- Inspection Readiness in Pharmacovigilance Explains inspection readiness as an outcome of an effective pharmacovigilance quality system rather than a last-minute preparation exercise, and shows how evidence, governance and operational reality should remain continuously aligned. Read Article →
- Inspection Interviews in Pharmacovigilance Explains the purpose and conduct of pharmacovigilance inspection interviews, the difference between QPPV and SME interviews, how inspectors test responsibilities, governance and system effectiveness, and how interviewees should prepare without relying on scripts or memorised answers. Read Article →
- Inspection Hosting for QPPVs Explains how the EU QPPV should prepare for and participate in pharmacovigilance inspections, how hosting roles should be organised, how evidence and interviews are managed, and how the QPPV demonstrates effective system oversight without becoming the operational owner of every inspection task. Read Article →
- Inspection Findings in Pharmacovigilance Explains how pharmacovigilance inspection findings arise from evidence, how EU inspection procedures classify critical, major and minor deficiencies, and how marketing-authorisation holders should move from finding assessment to proportionate CAPA, effectiveness verification and regulatory follow-up. Read Article →
- Common Pharmacovigilance Inspection Failures A practical guide to governance, QPPV oversight, vendors, data integrity, CAPA and inspection evidence. Read Article →
- PSMF and Pharmacovigilance System Governance Findings: What EU Inspectors Test A practical examination of PSMF and pharmacovigilance-system governance inspection findings, including evidence, common failure modes and QPPV oversight. Read Article →
- EU Pharmacovigilance Inspection Findings: Recurring Patterns and What Inspectors Actually Test A practical introduction to EU pharmacovigilance inspection findings, grounded in EMA PhV Inspectors Working Group reports and Union inspection procedures. Read Article →